Innovating Works

LUMENSIA SENSORS

Activa
PHOTONGATE: Development of photonic multi-sensing systems based on molecular-gates biorecognition and plasmonic sensors UNIVERSITAT POLITÈCNICA DE VALÈNCIA tramitó un HORIZON EUROPE: In the current world, there is a clear need of advanced multi-sensing systems capable of providing fast and quantitative detection of a huge range of hazards which could affect human health in our dai...
2022-11-17 | Financiado
PTQ2021-012051: Desarrollo y validación de nuevos métodos de detección de alérgenos alimentarios en diferentes matrices empleando biosensores fotónicos basados en anillos resonantes LUMENSIA SENSORS tramitó un AEI: TORRES QUEVEDO 2021 2021-01-01 | Financiado
GRACED: Ultra-compact, low-cost plasmo-photonic bimodal multiplexing sensor platforms as part of a holistic solution for food quality monitoring CY.R.I.C CYPRUS RESEARCH AND INNOVATION CENTER LTD tramitó un H2020: As consumer demand for fresh fruits and vegetables (F&V) continues to increase, so does the risk of microbiological and chemical contamination. Currently, inspections for F&V are carried out at the pr...
2021-01-01 | Financiado
SaPher: Disruptive Nano Photonics-based bio sensing platform for simultaneous analysis of multiple allergens in food industry UNIVERSITAT POLITÈCNICA DE VALÈNCIA tramitó un H2020: Food allergies affect over 17M people in Europe and increasing at a 2 digit prevalence rate. With no cure, the only successful method to prevent allergic reactions is to strictly avoid all foods conta...
2020-07-01 | Financiado
SWINOSTICS: Swine diseases field diagnostics toolbox CY.R.I.C CYPRUS RESEARCH AND INNOVATION CENTER LTD tramitó un H2020: The increased population density in modern animal production systems has made them vulnerable to various transboundary infectious agents & diseases. During the last decades in the developed world, a r...
2017-11-01 | Financiado
COBIOPHAD: COMPACT BIOPHOTONIC PLATFORM FOR DRUG ALLERGY DIAGNOSIS UNIVERSITAT POLITÈCNICA DE VALÈNCIA tramitó un H2020: Drug hypersensitivity to antibiotics, mainly Beta-lactams (BLCs) affects more than 2.5 million European citizens. Moreover, preventable adverse drug reactions are estimated in additional hospitalizati...
2016-01-01 | Financiado
PTQ-15-08036: Desarrollo de nuevas aplicaciones de sensores LUMENSIA SENSORS tramitó un AEI: 2015-01-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.